Litigation Details for Intercept Pharmaceuticals, Inc. v. MSN Laboratories Private Limited (D. Del. 2020)
✉ Email this page to a colleague
Intercept Pharmaceuticals, Inc. v. MSN Laboratories Private Limited (D. Del. 2020)
| Docket | 1:20-cv-01214 | Date Filed | 2020-09-10 |
| Court | District Court, D. Delaware | Date Terminated | 2023-02-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Patents | 10,047,117; 10,052,337; 10,174,073; 10,751,349; 10,758,549; 7,138,390; 9,238,673; RE48,286 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Intercept Pharmaceuticals, Inc. v. MSN Laboratories Private Limited
The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .
Biologic Drugs cited in Intercept Pharmaceuticals, Inc. v. MSN Laboratories Private Limited
The biologic drug covered by the patents cited in this case is ⤷ Start Trial .
Details for Intercept Pharmaceuticals, Inc. v. MSN Laboratories Private Limited (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-09-10 | External link to document | |||
| 2020-09-10 | 14 | SO ORDERED | Stipulation to Substitute U.S. Patent No. RE48,286 for U.S. Patent No. 7,138,390 and to Amend the Case Caption… 24 February 2023 1:20-cv-01214 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2020-09-10 | 21 | Complaint - Amended | 589 RE286 Patent”);1 9,238,673 (filed June 17, 2013) (“the ’673 Patent”); 10,047,117 (filed Nov. 20…073 Patent”); and 10,758,549 (filed Feb. 11, 2020) (“the ’549 Patent”) (collectively the “patents-in-… 1 The RE286 Patent is a reissue of U.S. Patent No. 7,138,390 (“the ’390 Patent”), which was originally…expiration of patents listed in the Orange Book for OCALIVA®, the ’549 Patent and the RE286 Patent. Hence, …1. This action for patent infringement, brought pursuant to the patent laws of the United States | External link to document |
| 2020-09-10 | 22 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673; 10,047,117; 10,052,337; …10 September 2020 1:20-cv-01214 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2020-09-10 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2 ;10,047,117 B2 ;10,052,…10 September 2020 1:20-cv-01214 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
